Clinical Value And Applicable Scenarios Of Bone Marrow Biopsy

https://www.chamfondbiotech.com/4-types-of-bone-marrow-biopsy-needles/

Bone marrow examination is the core diagnostic basis for hematological system diseases, mainly including bone marrow puncture aspiration and bone marrow biopsy. Most people are familiar with conventional bone marrow puncture, but lack a comprehensive understanding of the unique clinical advantages of bone marrow biopsy. In clinical practice, bone marrow biopsy is also an essential technical means to observe and evaluate bone marrow hematopoiesis, but it makes up for many inherent limitations of simple puncture and aspiration. Simple bone marrow puncture can only extract bone marrow fluid for cell smear observation, which is prone to sampling deviation and cannot reflect the overall structural state of bone marrow tissue. In contrast, bone marrow biopsy can obtain complete bone marrow tissue specimens, intuitively display the distribution of bone marrow cells, trabecular bone structure, tissue fibrosis degree and lesion infiltration range, and realize a more detailed, three-dimensional and comprehensive judgment of bone marrow status, which is irreplaceable in the precise diagnosis of complex hematological diseases.

The most prominent advantage of bone marrow biopsy is to solve the clinical dilemma of "dry tap" in puncture operation. In clinical cases such as myelofibrosis, severe bone marrow hyperplasia disorder and bone marrow cavity occlusion, conventional bone marrow puncture often fails to extract effective bone marrow fluid due to tissue fibrosis and cavity stenosis, resulting in missed diagnosis and misdiagnosis. Bone marrow biopsy, by obtaining solid bone marrow tissue samples, can still complete effective pathological detection under such special pathological conditions, providing accurate diagnostic basis for intractable hematological diseases. Based on its unique technical advantages, bone marrow biopsy has formed a complete and standardized indication system in clinical diagnosis, covering cytological diagnosis and etiological detection two core fields.

In terms of cytological examination indications, bone marrow biopsy is the gold standard for the diagnosis and typing of various leukemia diseases. It can accurately observe the proliferation, differentiation and infiltration of abnormal leukemia cells in bone marrow tissue, judge the degree of bone marrow lesion involvement, and provide basis for disease typing, treatment scheme formulation and prognosis judgment. For malignant tumor diseases involving bone marrow, including lymphoma, multiple myeloma and various solid tumor bone marrow metastases, biopsy can clearly detect tiny tumor infiltration lesions that are easy to be missed by simple puncture, realizing early staging and metastatic evaluation of tumors.

In addition, it has important differential diagnostic value for various benign and refractory hematological diseases. For various types of anemia with unclear etiology, hypersplenism, aleukemic leukemia and malignant histiocytosis, the comprehensive tissue structure information provided by biopsy can help clinicians distinguish benign hyperplasia from malignant lesions, avoid diagnostic confusion caused by single cell smear results, and greatly improve the accuracy of differential diagnosis of difficult hematological diseases.

In terms of etiological examination indications, bone marrow biopsy and corresponding smear culture technology expand the detection boundary of infectious diseases. For parasitic infectious diseases such as malaria and kala-azar, pathogens often parasitize in bone marrow tissue in latent infection stages, and bone marrow smear biopsy can significantly improve the positive detection rate compared with peripheral blood examination, realizing early diagnosis of latent infections. For acute infectious diseases such as typhoid fever and various sepsis, bone marrow culture based on biopsy specimens is less affected by antibacterial drugs and peripheral blood bacterial load, and the positive rate is significantly higher than conventional blood culture, which can effectively identify pathogenic bacteria for patients with negative blood culture and clinically suspected infection, providing accurate guidance for targeted anti-infection treatment.

In clinical application, bone marrow biopsy also has clear contraindications to ensure medical safety. Hemophilia patients have congenital coagulation dysfunction, and invasive biopsy operation is extremely prone to uncontrollable bleeding, which is a absolute contraindication of the operation. Patients with sternal malformation have abnormal local anatomical structure, thin cortical bone and adjacent important mediastinal organs, so sternal biopsy is not recommended to avoid the risk of organ injury. In addition, for all patients with bleeding tendency such as thrombocytopenia and coagulation factor deficiency, biopsy operation must be treated with caution, with standardized preoperative evaluation and intraoperative hemostasis to reduce surgical risks.

To sum up, bone marrow biopsy is an upgraded and complementary technology of conventional bone marrow puncture. It solves the pain points of insufficient information and easy failure of puncture aspiration, and covers the diagnosis of malignant hematological diseases, tumor metastasis, refractory anemia and infectious diseases. It is an indispensable core technology in modern hematological diagnosis, and its clinical popularization and standardized application are of great significance to improve the overall diagnosis level of hematological and systemic infectious diseases.